- $0.56m
- $26.78m
- $64.83m
Brief: Venus Concept reports Q2 results
Brief: Venus Concept Enters Into Purchase Agreement With Lincoln Park Capital Fund
Venus Concept Inc reports results for the quarter ended in March - Earnings Summary
Venus Concept Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Venus Concept Receives New FDA 510(K) Clearance For Venus Blissmax
Brief: Venus Concept Submits FDA 510(K) Related To The Use Of Its Aime Next Generation Robotic Technology For Tissue Excision And Skin Resurfacing
U.S. STOCKS ON THE MOVE-Verastem, Nio, metal miners
U.S. STOCKS ON THE MOVE-DatChat Inc, HP Inc, Natural gas firms
Venus Concept up on strong forecast, results
Brief: Venus Concept Announces Q4 Results
Venus Concept Inc reports results for the quarter ended in December - Earnings Summary
Venus Concept Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Venus Concept Says On Jan 14 Board Appointed Stanley Tyler Hollmig, M.D. To Serve As Class II Director
Brief: Venus Concept Receives FDA 510(K) Clearance Of Venus Blissmax For Non-Invasive Lipolysis Of The Abdomen And Flanks, Cellulite Reduction And Muscle Conditioning
Brief: Venus Concept Files Prospectus Relates To Resale, From Time To Time, By Selling Stockholders Of Up To 13.6 Million Shares Of Common Stock
Venus Concept Inc reports results for the quarter ended in September - Earnings Summary
Brief: Venus Concept Announces Third Quarter Financial Results
Venus Concept Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Venus Concept Receives FDA 510(K) Clearance For The Venus Freedom